Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Endocrine Journal|July 16, 2011
Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasisTae-Yon Sung, Sang-Ryung Lee, Jae Hoon Lee, et al.
Annals of Surgical Oncology|January 29, 2017
Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?Yi Ho Lee, Yu Mi Lee, Tae Yon Sung, et al.
European Journal of Endocrinology|November 20, 2012
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinomaMin Ji Jeon, Jong Ho Yoon, Ji Min Han, et al.
European Radiology|December 14, 2016
Treatment Efficacy and Safety of Ethanol Ablation for Thyroglossal Duct Cysts: A Comparison with SurgeryMi Sun Chung, Jung Hwan Baek, Jeong Hyun Lee, et al.
Nuclear Medicine Communications|August 19, 2011
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinomaEui Young Kim, Tae Yong Kim, Won Gu Kim, et al.
Clinical Endocrinology|January 29, 2010
Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablationEui Young Kim, Won Gu Kim, Won Bae Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2013
Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer populationJi Hye Yim, Won Gu Kim, Min Ji Jeon, et al.
European Journal of Endocrinology|January 17, 2017
A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort studyHyemi Kwon, Min Ji Jeon, Won Gu Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2010
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scanWon Gu Kim, Jin-Sook Ryu, Eui Young Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|July 12, 2012
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatmentJi Min Han, Won Bae Kim, Ji Hye Yim, et al.
Pageof 7